CC
AMED

Cypress Capital’s Amedisys AMED Stock Holding History

Cypress Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$4.59K – 91
2024
Q2 		$4.59K Buy
+50
New +$4.64K ﹤0.01% 239
2022
Q3 		– Sell
-4,830
Closed -$508K – 96
2022
Q2 		$508K Hold
4,830
– – 0.07% 130
2022
Q1 		$832K Hold
4,830
– – 0.1% 122
2021
Q4 		$782K Hold
4,830
– – 0.09% 128
2021
Q3 		$720K Buy
+4,830
New +$1M 0.09% 123

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cypress Capital's AMED Position: Q3 2024 in Review

Cypress Capital sold out of Amedisys (AMED) in Q3 2024, closing a stake of 50 shares — an estimated $4.59K sold.

Cypress Capital first reported a position in AMED in Q3 2021 and held it in 5 quarters. The position peaked at $832K in Q1 2022. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Cypress Capital reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Cypress Capital sold 50 Amedisys shares in Q3 2024, an estimated $4.59K.
  • Cypress Capital first reported a position in Amedisys in Q3 2021 and held it in 5 quarters.
  • Cypress Capital's Amedisys position peaked at $832K in Q1 2022.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Cypress Capital's 13F filing for Q3 2024, filed 12 Nov 2024.